Eswatini vs Tuvalu: Hepatitis B surface antigen (HBsAg) prevalence
Eswatini
1.2%
in 2024
Tuvalu
1.1%
in 2024
Eswatini rank
25th
Tuvalu rank
26th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Eswatini
- Tuvalu
How they compare
Eswatini currently reports 1.2% against 1.1% in Tuvalu, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Tuvalu's.
Across all 10 years both countries report, Eswatini has been ahead every year.
Eswatini ranks 25th and Tuvalu ranks 26th of 194 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.3% | 0.2% | Eswatini |
| 2020s | 1.4% | 1.2% | 0.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Eswatini or Tuvalu?
- Eswatini, at 1.2% against 1.1% in Tuvalu as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Eswatini and Tuvalu?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Tuvalu?
- 10 years are reported by both, from 2015 to 2024.
- How do Eswatini and Tuvalu rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Eswatini ranks 25th and Tuvalu ranks 26th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.